CORRECTION OF RENAL FUNCTION BY DESMOPRESSIN AND DICLOFENAC IN INCONTINENT WOMEN WITH NOCTURIA

Natalya Osipova; Dariko  Niauri; Alexandr  Gzgzyan; Lyailya  Dzhemlikhanova

doi:10.21638/11701/spbu11.2017.205

Authors

Natalya Osipova St Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation
Dariko Niauri St Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation https://orcid.org/0000-0003-1556-248X
Alexandr Gzgzyan St Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation
Lyailya Dzhemlikhanova St Petersburg State University, 7–9, Universitetskaya nab., St. Petersburg, 199034, Russian Federation

DOI:

https://doi.org/10.21638/11701/spbu11.2017.205

Abstract

The purpose of this study was to evaluate the clinical efficiency of desmopressine and diclofenac in incontinent patients with nocturnal polyuria and polyuria. A total of 277 patients ≥18 ≤ 55 years of age with complaints of urinary incontinence were included. 143 women had stress incontinence, 43 — urge incontinence and 91 — mixed incontinence. The overall prevalence of nocturia was 34.7 ± 2.9% (96 women).The frequency of poliuriya was 7 ± 2.1 % in stress incontinence, 11.6 ± 4.9 % in urge incontinence and 9.9 ± 3.1 % in mixed incontinence (p > 0.05). The frequency of nocturnal polyuria was 17.5 ± 3.2% in stress incontinence, 27.9 ± 6.8% in urge incontinence and 25.3 ± 4.6 % mixed incontinence (p > 0.05). Patients were randomized to receive either desmopressin or diclofenac in a double — blind fashion. The statistically significant recovery of renal function occurred in 8 incontinent women with polyuria and 19 with nocturnal polyuria who received diclofenac and in 12 incontinent women with polyuria and 18 with nocturnal polyuria who received desmopressin (Minirin). Refs 5. Figs 12. Table 1.

Keywords:

renal osmoregulatoin function, incontinence, sodium excretion, desmopressin, diclofenac

Downloads

Download data is not yet available.

References

References

Sand P. K., Dmochowski R. R., Reddy J., Van der Meulen E. A. Efficacy and Safety of Low Dose Desmopressin Orally Disintegrating Tablet in Women with Nocturia: Results of a Multicenter, Randomized,

Double-Blind, Placebo Controlled, Parallel Group Study. The Journal of urology, 2013, vol. 190 (3), pp. 958–964.

Breyer M. D., Jacobson H. R., Hebert R. L. Cellular mechanisms of prostaglandin E2 and vasopressin interactions in the collecting duct. Kidney Int., 1990, vol. 38 (4), pp. 618–624.

Clinical guidelines for nocturia. Committee for Establishment of the Clinical Guidelines for Nocturia of the Neurogenic Bladder Society. Int. J. Urol., 2010, vol. 17 (5), pp. 397–409.

Osipova N. A, Niauri D. A, Gzgzyan A. M. Ionoreguliruiushchaia funktsiia pochekpri razlichnykh tipakh nederzhaniia mochi u zhenshchin [Renal ionoregulation function in incontinent women]. Zhurnal akusherstva I zhenskikh boleznei [Journal of obstetrics and women ’s diseases], 2016, 65 (2), pp. 44–53. (In

Russian)

Greger R. Renal handling of the individual solutes of glomerular filtrate. Comprehensive human physiology. Eds R. Greger, U. Windhorst. Berlin, Heidelberg, 1996, vol. 2, pp. 1517–1544.